A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or Overweight
Public ClinicalTrials.gov record NCT06962280. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Evaluating the Efficacy and Long-Term Safety of Tirzepatide Once Weekly Compared to Placebo in Adults With Type 1 Diabetes and Obesity or Overweight
Study identification
- NCT ID
- NCT06962280
- Recruitment status
- Active, not recruiting
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Eli Lilly and Company
- Industry
- Enrollment
- 465 participants
Conditions and interventions
Conditions
Interventions
- Placebo Drug
- Tirzepatide Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 11, 2025
- Primary completion
- Oct 31, 2026
- Completion
- Jun 30, 2027
- Last update posted
- Feb 16, 2026
2025 – 2027
United States locations
- U.S. sites
- 18
- U.S. states
- 9
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Kaiser Permanente Bonita Medical Offices | Bonita | California | 91902 | — |
| AMCR Institute | Escondido | California | 92025 | — |
| Mary & Dick Allen Diabetes Center | Newport Beach | California | 92663 | — |
| University Clinical Investigators, Inc. | Tustin | California | 92780 | — |
| University of Colorado Anschutz Medical Campus | Aurora | Colorado | 80045 | — |
| Metabolic Research Institute, Inc. | West Palm Beach | Florida | 33401 | — |
| Iowa Diabetes and Endocrinology Research Center | West Des Moines | Iowa | 50266 | — |
| HealthPartners Institute dba International Diabetes Center | Minneapolis | Minnesota | 55416 | — |
| Clinical Research Professionals | Chesterfield | Missouri | 63005 | — |
| Clinvest Headlands Llc | Springfield | Missouri | 65807 | — |
| Las Vegas Endocrinology | Henderson | Nevada | 89074 | — |
| University of North Carolina Medical Center | Chapel Hill | North Carolina | 27514 | — |
| Velocity Clinical Research, Dallas | Dallas | Texas | 75230 | — |
| Juno Research | Houston | Texas | 77040 | — |
| Southern Endocrinology Associates | Mesquite | Texas | 75149 | — |
| Texas Diabetes & Endocrinology, P.A. | Round Rock | Texas | 78681 | — |
| San Antonio Clinical Trials | San Antonio | Texas | 78240 | — |
| Texas Valley Clinical Research | Weslaco | Texas | 78596 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 61 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06962280, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 16, 2026 · Synced May 6, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT06962280 live on ClinicalTrials.gov.